STOCK TITAN

[Form 4] Natera, Inc. Insider Trading Activity

Filing Impact
(High)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Natera, Inc. (NTRA): CFO reported open‑market sales on Form 4. The Chief Financial Officer executed multiple sales of common stock on 10/27/2025, 10/28/2025, and 10/29/2025. Reported transactions include 781 shares at $192.324 on 10/27, 1,237 shares on 10/28 at a weighted average price, and additional sales on 10/28 and 10/29 at weighted average prices within stated ranges. Following the reported transactions, the officer directly owned 64,126 shares.

Footnotes state that the 10/27 sale and the first 10/28 sale were effected to satisfy tax withholding and remittance obligations upon RSU vesting, pursuant to a written instruction intended to satisfy Rule 10b5‑1(c). The remaining sales were effected under a Rule 10b5‑1 trading plan adopted on June 14, 2024. Several prices are reported as weighted averages with detailed per‑trade ranges available upon request.

Natera, Inc. (NTRA): il CFO ha riportato vendite sul mercato aperto su Form 4. Il direttore finanziario ha eseguito molteplici vendite di azioni ordinarie il 27/10/2025, il 28/10/2025 e il 29/10/2025. Le transazioni riportate includono 781 azioni a 192,324 USD il 27/10, 1.237 azioni il 28/10 a un prezzo medio ponderato, e ulteriori vendite il 28 e il 29/10 a prezzi medi ponderati entro gli intervalli indicati. Dopo le transazioni riportate, l'ufficiale possedeva direttamente 64.126 azioni. Le note a piè di pagina indicano che la vendita del 27/10 e la prima vendita del 28/10 sono state effettuate per soddisfare gli obblighi fiscali di trattenuta e versamento al momento della vesting degli RSU, ai sensi di un'istruzione scritta volta a soddisfare la Rule 10b5‑1(c). Le restanti vendite sono state eseguite nell'ambito di un piano di negoziazione Rule 10b5‑1 adottato il 14 giugno 2024. Diversi prezzi sono riportati come medie ponderate con intervalli dettagliati per ogni operazione disponibili su richiesta.

Natera, Inc. (NTRA): el CFO informó ventas en el mercado abierto en el Formulario 4. El Director Financiero ejecutó múltiples ventas de acciones comunes el 27/10/2025, 28/10/2025 y 29/10/2025. Las transacciones reportadas incluyen 781 acciones a 192,324 USD el 27/10, 1.237 acciones el 28/10 a un precio medio ponderado, y ventas adicionales el 28 y el 29/10 a precios promedio ponderados dentro de los rangos indicados. Después de las transacciones reportadas, el funcionario poseía directamente 64.126 acciones. Las notas al pie indican que la venta del 27/10 y la primera venta del 28/10 se realizaron para cumplir con las obligaciones de retención e ingresos fiscales al vesting de las RSU, conforme a una instrucción por escrito destinada a cumplir la Regla 10b5‑1(c). Las ventas restantes se realizaron bajo un plan de negociación Rule 10b5‑1 adoptado el 14 de junio de 2024. Varios precios se reportan como promedios ponderados con rangos detallados por operación disponibles a solicitud.

나테라, Inc. (NTRA): CFO가 Form 4에 따른 공개시장 매매를 보고했습니다. 최고재무책임자는 2025년 10월 27일, 28일, 29일에 보통주를 다수 매도했습니다. 보고된 거래에는 2025년 10월 27일 781주를 192.324달러에, 10월 28일에 1,237주를 가중평균가로 매도했고, 10월 28일과 29일에 추가 매도가 지정된 범위 내의 가중평균가로 이루어졌습니다. 보고된 거래 이후 임원은 직접 64,126주를 소유했습니다. 각주에 따르면 10월 27일 매도와 10월 28일의 첫 매도는 RSU vesting 시점에 따른 보유세 원가 납부 의무를 충족하기 위해 수행되었고, Rule 10b5‑1(c)을 충족시키려는 서면 지침에 따라 이루어졌습니다. 나머지 매매는 2024년 6월 14일에 채택된 Rule 10b5‑1 거래 계획에 따라 이루어졌습니다. 여러 가격은 거래별 상세 구간이 요청 시 제공되는 가중평균으로 보고됩니다.

Natera, Inc. (NTRA) : le directeur financier a signalé des ventes sur le marché ouvert sur le formulaire 4. Le directeur financier a effectué plusieurs ventes d'actions ordinaires les 27/10/2025, 28/10/2025 et 29/10/2025. Les transactions déclarées comprennent 781 actions à 192,324 USD le 27/10, 1 237 actions le 28/10 à un prix moyen pondéré, et des ventes supplémentaires les 28 et 29/10 à des prix moyens pondérés dans les fourchettes indiquées. Suite aux transactions déclarées, le dirigeant possédait directement 64 126 actions. Les notes de bas de page indiquent que la vente du 27/10 et la première vente du 28/10 ont été effectuées pour satisfaire les obligations de retenue et de versement d'impôt au moment du vesting des RSU, conformément à une instruction écrite destinée à satisfaire à la règle 10b5‑1(c). Les ventes restantes ont été effectuées dans le cadre d'un plan de négociation Rule 10b5‑1 adopté le 14 juin 2024. Plusieurs prix sont rapportés comme des moyennes pondérées avec des plages détaillées par transaction disponibles sur demande.

Natera, Inc. (NTRA): CFO meldete Verkäufe am offenen Markt im Formular 4. Der Chief Financial Officer führte am 27.10.2025, 28.10.2025 und 29.10.2025 mehrere Verkäufe von Stammaktien durch. Die gemeldeten Transaktionen umfassen 781 Aktien zu 192,324 USD am 27.10., 1.237 Aktien am 28.10. zu einem gewogenen Durchschnittspreis sowie zusätzliche Verkäufe am 28. und 29.10. zu gewogenen Durchschnittspreisen innerhalb der angegebenen Spannen. Nach den gemeldeten Transaktionen besaß der Offizier direkt 64.126 Aktien. Fußnoten besagen, dass der Verkauf am 27.10. und der erste Verkauf am 28.10. dazu dienten, steuerliche Abzugs- und Überweisungsverpflichtungen zum Zeitpunkt des RSU-Vesting zu erfüllen, gemäß einer schriftlichen Anweisung, die darauf abzielt, die Rule 10b5‑1(c) zu erfüllen. Die restlichen Verkäufe wurden im Rahmen eines am 14. Juni 2024 eingeführten Rule 10b5‑1-Handelsplans durchgeführt. Mehrere Preise werden als gewichtete Durchschnitte angegeben, mit detaillierten pro-Trade-Spannen auf Anfrage verfügbar.

ناتيرا، إنك. (NTRA): أبلغ المدير المالي عن مبيعات في السوق المفتوحة في النموذج 4. نفّذ المدير المالي التنفيذي عدة مبيعات للأسهم العادية في 27/10/2025، 28/10/2025 و29/10/2025. تشمل المعاملات المبلغ عنها 781 سهماً بسعر 192.324 دولار في 27/10، و1,237 سهماً في 28/10 بسعر متوسط وزني، ومبيعات إضافية في 28 و29/10 بأسعار متوسط وزن ضمن النطاقات المذكورة. بعد المعاملات المبلغ عنها، كان المسؤول يمتلك مباشرة 64,126 سهماً. تشير الهوامش إلى أن بيع 27/10 والبيع الأول في 28/10 تم لإشباع الالتزامات الضريبية الخاصة بالاقتطاع والتحويل عند vesting RSU، وفق توجيه كتابي يهدف إلى استيفاء القاعدة 10b5‑1(c). وتمت بقية المبيعات وفق خطة تداول Rule 10b5‑1 اعتمدت في 14 يونيو 2024. يُذكر أن عدداً من الأسعار مُبلغ عنها كمبالغ مئوية وزنية مع نطاقات تفصيلية لكل صفقة متاحة عند الطلب.

Positive
  • None.
Negative
  • None.

Insights

Analyzing...

Natera, Inc. (NTRA): il CFO ha riportato vendite sul mercato aperto su Form 4. Il direttore finanziario ha eseguito molteplici vendite di azioni ordinarie il 27/10/2025, il 28/10/2025 e il 29/10/2025. Le transazioni riportate includono 781 azioni a 192,324 USD il 27/10, 1.237 azioni il 28/10 a un prezzo medio ponderato, e ulteriori vendite il 28 e il 29/10 a prezzi medi ponderati entro gli intervalli indicati. Dopo le transazioni riportate, l'ufficiale possedeva direttamente 64.126 azioni. Le note a piè di pagina indicano che la vendita del 27/10 e la prima vendita del 28/10 sono state effettuate per soddisfare gli obblighi fiscali di trattenuta e versamento al momento della vesting degli RSU, ai sensi di un'istruzione scritta volta a soddisfare la Rule 10b5‑1(c). Le restanti vendite sono state eseguite nell'ambito di un piano di negoziazione Rule 10b5‑1 adottato il 14 giugno 2024. Diversi prezzi sono riportati come medie ponderate con intervalli dettagliati per ogni operazione disponibili su richiesta.

Natera, Inc. (NTRA): el CFO informó ventas en el mercado abierto en el Formulario 4. El Director Financiero ejecutó múltiples ventas de acciones comunes el 27/10/2025, 28/10/2025 y 29/10/2025. Las transacciones reportadas incluyen 781 acciones a 192,324 USD el 27/10, 1.237 acciones el 28/10 a un precio medio ponderado, y ventas adicionales el 28 y el 29/10 a precios promedio ponderados dentro de los rangos indicados. Después de las transacciones reportadas, el funcionario poseía directamente 64.126 acciones. Las notas al pie indican que la venta del 27/10 y la primera venta del 28/10 se realizaron para cumplir con las obligaciones de retención e ingresos fiscales al vesting de las RSU, conforme a una instrucción por escrito destinada a cumplir la Regla 10b5‑1(c). Las ventas restantes se realizaron bajo un plan de negociación Rule 10b5‑1 adoptado el 14 de junio de 2024. Varios precios se reportan como promedios ponderados con rangos detallados por operación disponibles a solicitud.

나테라, Inc. (NTRA): CFO가 Form 4에 따른 공개시장 매매를 보고했습니다. 최고재무책임자는 2025년 10월 27일, 28일, 29일에 보통주를 다수 매도했습니다. 보고된 거래에는 2025년 10월 27일 781주를 192.324달러에, 10월 28일에 1,237주를 가중평균가로 매도했고, 10월 28일과 29일에 추가 매도가 지정된 범위 내의 가중평균가로 이루어졌습니다. 보고된 거래 이후 임원은 직접 64,126주를 소유했습니다. 각주에 따르면 10월 27일 매도와 10월 28일의 첫 매도는 RSU vesting 시점에 따른 보유세 원가 납부 의무를 충족하기 위해 수행되었고, Rule 10b5‑1(c)을 충족시키려는 서면 지침에 따라 이루어졌습니다. 나머지 매매는 2024년 6월 14일에 채택된 Rule 10b5‑1 거래 계획에 따라 이루어졌습니다. 여러 가격은 거래별 상세 구간이 요청 시 제공되는 가중평균으로 보고됩니다.

Natera, Inc. (NTRA) : le directeur financier a signalé des ventes sur le marché ouvert sur le formulaire 4. Le directeur financier a effectué plusieurs ventes d'actions ordinaires les 27/10/2025, 28/10/2025 et 29/10/2025. Les transactions déclarées comprennent 781 actions à 192,324 USD le 27/10, 1 237 actions le 28/10 à un prix moyen pondéré, et des ventes supplémentaires les 28 et 29/10 à des prix moyens pondérés dans les fourchettes indiquées. Suite aux transactions déclarées, le dirigeant possédait directement 64 126 actions. Les notes de bas de page indiquent que la vente du 27/10 et la première vente du 28/10 ont été effectuées pour satisfaire les obligations de retenue et de versement d'impôt au moment du vesting des RSU, conformément à une instruction écrite destinée à satisfaire à la règle 10b5‑1(c). Les ventes restantes ont été effectuées dans le cadre d'un plan de négociation Rule 10b5‑1 adopté le 14 juin 2024. Plusieurs prix sont rapportés comme des moyennes pondérées avec des plages détaillées par transaction disponibles sur demande.

Natera, Inc. (NTRA): CFO meldete Verkäufe am offenen Markt im Formular 4. Der Chief Financial Officer führte am 27.10.2025, 28.10.2025 und 29.10.2025 mehrere Verkäufe von Stammaktien durch. Die gemeldeten Transaktionen umfassen 781 Aktien zu 192,324 USD am 27.10., 1.237 Aktien am 28.10. zu einem gewogenen Durchschnittspreis sowie zusätzliche Verkäufe am 28. und 29.10. zu gewogenen Durchschnittspreisen innerhalb der angegebenen Spannen. Nach den gemeldeten Transaktionen besaß der Offizier direkt 64.126 Aktien. Fußnoten besagen, dass der Verkauf am 27.10. und der erste Verkauf am 28.10. dazu dienten, steuerliche Abzugs- und Überweisungsverpflichtungen zum Zeitpunkt des RSU-Vesting zu erfüllen, gemäß einer schriftlichen Anweisung, die darauf abzielt, die Rule 10b5‑1(c) zu erfüllen. Die restlichen Verkäufe wurden im Rahmen eines am 14. Juni 2024 eingeführten Rule 10b5‑1-Handelsplans durchgeführt. Mehrere Preise werden als gewichtete Durchschnitte angegeben, mit detaillierten pro-Trade-Spannen auf Anfrage verfügbar.

ناتيرا، إنك. (NTRA): أبلغ المدير المالي عن مبيعات في السوق المفتوحة في النموذج 4. نفّذ المدير المالي التنفيذي عدة مبيعات للأسهم العادية في 27/10/2025، 28/10/2025 و29/10/2025. تشمل المعاملات المبلغ عنها 781 سهماً بسعر 192.324 دولار في 27/10، و1,237 سهماً في 28/10 بسعر متوسط وزني، ومبيعات إضافية في 28 و29/10 بأسعار متوسط وزن ضمن النطاقات المذكورة. بعد المعاملات المبلغ عنها، كان المسؤول يمتلك مباشرة 64,126 سهماً. تشير الهوامش إلى أن بيع 27/10 والبيع الأول في 28/10 تم لإشباع الالتزامات الضريبية الخاصة بالاقتطاع والتحويل عند vesting RSU، وفق توجيه كتابي يهدف إلى استيفاء القاعدة 10b5‑1(c). وتمت بقية المبيعات وفق خطة تداول Rule 10b5‑1 اعتمدت في 14 يونيو 2024. يُذكر أن عدداً من الأسعار مُبلغ عنها كمبالغ مئوية وزنية مع نطاقات تفصيلية لكل صفقة متاحة عند الطلب.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Brophy Michael Burkes

(Last) (First) (Middle)
C/O NATERA, INC.
13011 MCCALLEN PASS BUILDING A SUITE 100

(Street)
AUSTIN TX 78753

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Natera, Inc. [ NTRA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
CHIEF FINANCIAL OFFICER
3. Date of Earliest Transaction (Month/Day/Year)
10/27/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 10/27/2025 S 781(1) D $192.324 68,408 D
Common Stock 10/28/2025 S 1,237(2) D $191.4619 67,171 D
Common Stock 10/28/2025 S 574(3) D $189.8977(4) 66,597 D
Common Stock 10/28/2025 S 404(3) D $191.5086(5) 66,193 D
Common Stock 10/28/2025 S 200(3) D $192.195(6) 65,993 D
Common Stock 10/29/2025 S 300(3) D $188.3733(7) 65,693 D
Common Stock 10/29/2025 S 400(3) D $189.9085(8) 65,293 D
Common Stock 10/29/2025 S 667(3) D $190.9913(9) 64,626 D
Common Stock 10/29/2025 S 500(3) D $192.116(10) 64,126 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 26, 2024.
2. The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 27, 2023.
3. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2024.
4. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $189.49 to 190.26 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
5. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $190.88 to $191.80 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
6. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $191.93 to $192.46 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
7. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $188.06 to $189.00 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
8. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $189.24 to $190.05 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
9. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $190.42 to $191.41 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
10. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $191.98 to $192.29 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
/s/ Vincent Fontanilla, Attorney-in-Fact 10/29/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Natera (NTRA) disclose in this Form 4?

The CFO reported multiple sales of Natera common stock on 10/27/2025, 10/28/2025, and 10/29/2025, with prices reported per transaction.

How many Natera (NTRA) shares did the officer hold after these transactions?

After the reported transactions, the officer directly owned 64,126 shares.

What were examples of the sale prices reported?

Examples include $192.324 on 10/27/2025 and weighted average prices on 10/28 and 10/29 within the stated ranges in the footnotes.

Were any sales related to tax withholding for RSU vesting at NTRA?

Yes. The 10/27 sale and the first 10/28 sale were to satisfy tax withholding and remittance obligations tied to RSU vesting.

Did the Natera CFO use a Rule 10b5-1 plan?

Yes. The remaining sales were effected under a Rule 10b5‑1 trading plan adopted on June 14, 2024.

Are the reported prices exact or averages?

Several entries are weighted average prices, with per‑trade ranges provided in the footnotes and full details available upon request.
Natera Inc

NASDAQ:NTRA

NTRA Rankings

NTRA Latest News

NTRA Latest SEC Filings

NTRA Stock Data

26.02B
132.34M
3.2%
96.35%
2.7%
Diagnostics & Research
Services-medical Laboratories
Link
United States
AUSTIN